论文部分内容阅读
在加息利空出来后,大盘依托银行、地产和医药三大板块的联合做多力量再次突破3000点,至收市时报收于3014点,这也是中国股市历史上第二次成功站在3000点之上,其意义影响深远。盘面上,两市个股进一步活跃,特别是作为主攻3000点的之一的医药板块更是黑马频出,涨声一片。像被控股股东加速资产整合的医药龙头股四环药业(10．86,0．00,0．00%)已经是复牌后的第4个涨停,还有明显具有抗跌性的东北制药(7．36, 0．34,4．84%)连续2天涨停,还有太极集团(13．19,0．08,0．61%)、广济药业(8．45,0．33,4．06%)等医药股也强势涨停,完全将医药股强大的财富效应发挥得淋漓尽致。
After the interest rate hiked, the broader market relied on the cooperation of banks, real estate and medicine to make more breakthroughs of 3,000 points once again to close at 3014 points, which is the second time in the history of China’s stock market standing at 3000 points On the meaning of far-reaching impact. Disk, the two cities further active stocks, especially as one of the main point of the 3000 pharmaceutical sector is a dark horse, a rising tone. As controlled by the controlling shareholder of the pharmaceutical sector to speed up the integration of assets Fourth Ring Pharmaceutical has been the resumption of trading after the fourth daily limit, there is clearly defensive Northeast Pharmaceutical (7 .36, 0.34,4.84%) daily limit for 2 days, there are Taiji Group (13.19,0.08,0.61%), Guangji Pharmaceutical (8.45,0.33,4 .06%) and other pharmaceutical stocks are also a strong daily limit, the full strength of the pharmaceutical stocks play a full wealth effect.